1. Japan Stocks

  2. •

    Industrials

  3. •

    Industrial - Pollution & Treatment Controls
Organo Corporation

Organo Corporation

ORGJF
Organo CorporationUS flagOther OTC
100.46
USD
- -
- -
4.62BMarket Cap
Organo Corporation
ORGJF
(Other OTC)

Recent

price

100.46

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1,325.15
1,486.02
1,447.52
1,347.43
1,491.88
1,708.76
1,761.05
1,720.51
2,012.76
2,109.16
2,193.5
2,441.7
2,887.43
3,273.96
3,551.83
- -
1,847.61
Revenue per Share
40.28
58.2
55.63
14.41
23.55
53.94
59.29
60.37
97.11
156.51
154.18
200.66
255.76
376.92
525.37
- -
256.22
Basic EPS, GAAP
60.25
-135.39
-50.38
153.69
-65.91
-119.39
114.26
-11.34
109.68
165.76
-127.2
174.06
-435.82
45.27
400.52
- -
- -
Free Cash Flow per Basic Share
10
14.99
14.99
12.5
9.98
9.99
12.48
13.75
14.31
22.88
27.33
33.57
51.17
74.14
132.14
- -
- -
Dividend per Share
731.82
775.16
816.25
814.8
826.9
870.3
738.67
964.1
1,051.22
1,186.76
1,310.53
1,478.15
1,683.86
1,984.37
2,375.74
- -
2,099.46
Book Value per Share
883.78
924.89
973.74
952.2
973.27
996.35
1,042.71
1,096.79
1,168.88
1,305.59
1,444.03
1,632.36
1,862.53
2,202.73
2,612.12
- -
2,339.27
Tangible Book Value per Share
46
46
46
46
46
46
46
46
46
46
46
46
46
46
46
- -
46
Basic Weighted Avg Shares
61,097
68,502
66,718
62,096
68,741
78,719
81,114
79,226
92,273
96,515
100,638
112,069
132,426
150,356
163,269
177,654
84,887
Sales/Revenue/Turnover
5.78
7.08
5.24
1.34
3.49
5.02
23
4.82
7.11
10.27
9.52
9.68
11.49
14.99
19.06
21.19
17.3
Operating Margin (%)
1,210
1,190
1,159
1,065
999
950
950
972
920
1,189
1,212
1,332
1,824
2,010
1,925
1,981
- -
Depreciation Expense
1,857
2,683
2,564
664
1,085
2,485
2,731
2,780
4,452
7,162
7,074
9,210
11,730
17,310
24,150
28,401
11,772
Net Income, GAAP
39.46
45.19
33.61
43.05
44.76
34.81
31.08
28.39
30.05
27.19
26.9
27.33
26.63
26.65
25.25
25.86
21.93
Effective Tax Rate (%)
3.04
3.92
3.84
1.07
1.58
3.16
3.37
3.51
4.82
7.42
7.03
8.22
8.86
11.51
14.79
15.99
13.87
Profit Margin (%)
22,723
29,009
28,680
26,941
31,063
32,407
32,965
33,333
36,107
43,838
48,953
59,790
68,027
80,867
99,966
121,063
86,387
Working Capital
3,454
6,753
4,053
2,552
4,402
3,801
2,601
1,401
200
2,095
1,495
5,695
3,895
2,400
3,680
6,000
1,800
LT Debt
41,116
43,015
45,207
44,252
45,308
46,567
49,034
51,680
54,795
60,857
67,357
76,004
86,370
102,146
121,193
142,961
108,488
Total Equity
4.02
4.76
3.91
0.82
2.34
4.18
19.55
4.06
6.64
10.12
8.86
8.83
10.36
12.5
15.99
16.78
8.57
Return on Invested Capital (%)
4.22
5.7
5.1
1.43
2.28
4.67
5.07
5.04
7.37
11.49
10.18
11.62
12.17
14.66
18.7
19.37
9.93
Return on Capital (%)
5.62
7.72
6.99
1.77
2.87
6.36
7.37
7.09
9.62
13.97
12.36
14.39
16.17
20.56
24.11
23.83
13.25
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
34,065
- -
24,050
LT Borrowings
2,400
- -
1,800
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
- -
46
Market Capitalization
187,638
65,159
178,309

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
153,469
- -
151,315
Cash, Cash Equivalents & STI
45,456
- -
51,972
Accounts Receivable, Net
44,121
- -
74,558
Inventories
21,830
- -
17,114
Total Current Liabilities
72,602
- -
64,928
Payables & Accruals
- -
- -
- -
ST Debt
34,065
- -
24,050
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.98%
16.27%
17.96%
Free Cash Flow
-145.13%
8.72%
-44.47%
Net Income, GAAP
29.37%
32.45%
17.6%
Sales/Revenue/Turnover
8.65%
12.09%
8.81%
Total Cash Common Dividend
35.61%
47.61%
39.4%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29,612
35,857
40,767
44,120
150,356
2025
- -
- -
- -
- -
163,269
2026
- -
- -
- -
- -
177,654

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
34.8
- -
- -
- -
376.92
2025
- -
- -
- -
- -
525.37
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
74.14
2025
- -
- -
- -
- -
132.14
2026
- -
- -
- -
- -
- -
Similar Companies
Sparta Capital Ltd. (SAY.V)
ClearSign Technologies Corporation (CLIR)
China Conch Venture Holdings Limited (CCVTF)
Kurita Water Industries Ltd. (KTWIF)
Ozner Water International Holding Limited (2014.HK)
Sionix Corp. (SINX)
Business
Organo Corporation engages in the water treatment engineering business and functional products business. The company manufactures, sells, maintains, and manages pure water systems, ultrapure water systems, wastewater treatment systems, and condensate demineralizers for power stations; standardized water treatment equipment, water treatment chemicals such as ion exchange resins and activated carbon, and food processing materials; as well as filtration equipment, reverse osmosis membranes, electrodeionization systems, and resource recovery systems for hydrofluoric acid, tetramethylammonium hydroxide, rare metals, and organic solvents. Organo operates primarily in Japan with additional presence in Taiwan, China, Southeast Asia, and other international markets, serving industries including electronics and semiconductors, pharmaceuticals and medical devices, energy, sugar production, water supply, and sewage treatment facilities. Founded on May 1, 1946, the company is headquartered at 1-2-8 Shinsuna, Koto-ku, Tokyo, Japan, and employs approximately 1,266 people as of March 2025. In 2025, Organo announced amendments to its corporate governance guidelines, released full-year FY03/25 financial results, issued notices regarding officer changes and organizational restructuring, and exhibited at the ISPE Facilities of the Future Conference.